Form 4: Nevro Corp. CFO Sells Shares to Cover Tax Obligations

Nevro Corp.'s Chief Financial Officer, Roderick H. MacLeod, sold 1,759 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Roderick H. MacLeod, the Senior Vice President and Chief Financial Officer of Nevro Corp., sold 1,759 shares of common stock on December 7, 2024.
• The sale was executed at a price of $4.19 per share.
• This transaction was to cover tax obligations associated with the vesting of restricted stock units.
• Following the transaction, MacLeod directly owns 131,359 shares of Nevro Corp., which includes 104,369 restricted stock units.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment. It is a neutral event.

Industry Context

This is a routine transaction for corporate executives who receive stock-based compensation. It is common for executives to sell shares to cover tax liabilities when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The sale of 1,759 shares is relatively small compared to the total holdings of 131,359 shares, suggesting this is a routine tax-related transaction rather than a significant divestment.
• Similar transactions are regularly reported by executives at comparable companies in the medical device industry.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders as it is a small sale by an executive to cover tax obligations.

Key Dates

Keywords

Nevro Corp, Roderick H. MacLeod, Form 4, insider trading, stock sale, restricted stock units, tax obligations, NVRO, CFO